Mixtard human 70/30 side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Mixtard human 70/30. Common side effects include cardiac arrest among females, and blood glucose increased among males.

The phase IV clinical study is created by eHealthMe based on 1,091 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 13, 2023

1,091 people who take Mixtard Human 70/30 and have side effects are studied.

What is Mixtard Human 70/30?

Mixtard human 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is used in type 1 diabetes. Currently, eHealthMe is studying from 1,105 Mixtard human 70/30 users.

Number of Mixtard human 70/30 reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Mixtard human 70/30?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Mixtard human 70/30) and Mixtard human 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Mixtard human 70/30:

Mixtard human 70/30 (1,105 reports)

All Mixtard human 70/30 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Herceptin and Seizures - a second ago
Linzess and Gastric Bypass - 2 seconds ago
Lupron and Uloric drug interaction - 4 seconds ago
Xeljanz Xr and Agitation Aggravated - 18 seconds ago
Tremfya and Taclonex drug interaction - 21 seconds ago
Optimark and Muscle Contracture - 24 seconds ago
Methylprednisolone and Lyrica drug interaction - 26 seconds ago
Afinitor and Chickenpox - 27 seconds ago
Whey Protein and Vyvanse drug interaction - 39 seconds ago
Wellbutrin Xl and Injection Site Haemorrhage - 46 seconds ago